The {pharmaceutical industry is currently exploring novel treatment strategies for obesity , and the arrival of semaglutide 10mg injectables represents a significant change. Clinicians are beginning to consider the possible benefits and risks associated with this higher strength product, particularly in comparison to existing standard semaglutide t